You are here

layoffs

Nektar guts workforce, weeks after $3.6B Bristol Myers immuno-oncology collaboration ends

Fierce Biotech

Mon, 04/25/22 - 10:53 pm

Nektar Therapeutics

Bristol Myers Squibb

Imara to reduce staff by 83% amid biotech shakeout

BioPharma Dive

Mon, 04/18/22 - 10:50 am

beta thalassemia

sickle cell disease

After February market crash, ProQR will lay off 30% of its workforce and try pushing eye therapy after failed trial

Endpoints

Wed, 04/13/22 - 10:46 am

Thousands of layoffs planned as part of Novartis restructuring — report

Endpoints

Tue, 04/12/22 - 11:02 am

Kaleido Biosciences Culls Staff, Prepares to Cease Operations

BioSpace

Sun, 04/10/22 - 07:45 pm

Kaleido Biosciences

In a one-two gut punch after kidney drug CRL, Akebia slapped with partial hold and will lay off 42% of staff

Endpoints

Thu, 04/7/22 - 10:49 am

Akebia Therapeutics

Sanofi cuts 2 dozen Kadmon staffers after $1.9B buyout: filing

Fierce Pharma

Wed, 04/6/22 - 12:26 pm

Feeling Blue: bluebird bio cuts staff by 30%, prepares for FDA decision

BioSpace

Tue, 04/5/22 - 11:55 am

In major shake-up, Novartis combines pharma and oncology units, leaving 3 top execs without jobs

Fierce Pharma

Mon, 04/4/22 - 11:00 am

Silverback falls on hard times, axing lead I/O candidates and laying off more than a fourth of staff

Endpoints

Fri, 04/1/22 - 10:35 am

Silverback Theraepeutics

immuno-oncology

Workforce Cuts Abound at Zealand Pharma, Merck and Orchard

BioSpace

Thu, 03/31/22 - 10:43 am

Orchard Therapeutics

Merck cuts 170 jobs at Acceleron right on heels of $11.5B buyout

Fierce Pharma

Wed, 03/30/22 - 11:05 am

'Stay alive': Wave of layoffs crashes into biotech startup inferno

Fierce Biotech

Mon, 03/28/22 - 10:38 am

Ovid Therapeutics

As biotech retreats, gene therapy companies retrench and redraw plans

BioPharma Dive

Thu, 03/24/22 - 08:29 pm

Merck telegraphs closure of Pennsylvania antibiotics plant that employs 300

Fierce Pharma

Thu, 03/24/22 - 11:27 am

drug manufacturing

A Bayer partner slims down, trimming R&D and enacting layoffs, to better focus on the pair's prostate cancer work

Endpoints

Thu, 03/24/22 - 10:53 am

prostate cancer

2seventy bio's honeymoon phase is over as job cuts hit 6% of staff

Fierce Biotech

Wed, 03/23/22 - 11:10 am

PhIII failure triggers layoffs, spending cuts and warning of 'dissolution' for single-minded biotech

Endpoints

Wed, 03/23/22 - 10:34 am

Neurana Pharmaceuticals

clinical trials

Zosano's headaches continue: Biotech lays off 31% after FDA rejects migraine drug resubmission

Fierce Biotech

Thu, 03/17/22 - 11:16 pm

Passage Bio to cut jobs in latest biotech restructuring

BioPharma Dive

Tue, 03/15/22 - 11:31 pm

Pages